Day: September 17, 2021

VANCOUVER, British Columbia, Sept. 17, 2021 (GLOBE NEWSWIRE) — Major Precious Metals Corp. (“Major Precious Metals” or the “Company”) (CSE:SIZE | OTC:SIZYF | FRANKFURT:3EZ) is pleased to announce that it has successfully completed its Phase 1 diamond drilling program at its Skaergaard Project (“Skaergaard”) in Greenland with all planned drill hole depths covering an area of approximately 10 km² within the 7.5 km (east-west) by 11 km (north-south) Skaergaard intrusion, including key new target zones in the northern part of the Project. HighlightsA total of 32 diamond drill holes (8,195 m) were completed in several key target areas in the northern part of Skaergaard. These target areas were discussed in the Company’s August 26, 2021 news release. Approximately 240 m of channel samples were also collected from four separate areas...

Press Release Nokia and Indosat Ooredoo launch 5G network in IndonesiaNokia’s latest 5G AirScale portfolio to be deployed across Indonesia’s central islands delivering incredible 5G experiences to subscribers Nokia and Indosat Ooredoo together with Sepuluh Nopember Institute of Technology (ITS) and the University of Oulu to launch the Nokia 5G Experience Center providing a platform for the development of innovative new use cases by local digital talent17 September 2021 Espoo, Finland – Nokia and Indosat Ooredoo today announced the launch of commercial 5G services in Surabaya city, Indonesia. Under the deal, Indosat Ooredoo’s customers will experience new enterprise and industrial use cases underpinned by the new 5G network. Nokia will supply equipment from its latest ReefShark based AirScale product range, including its AirScale...

– Interim results to be presented September 17 at the European Society for Medical Oncology (ESMO) Congress 2021 – – Data support the use of toripalimab with chemotherapy as first-line therapy for patients with ESCC – – Coherus and Junshi Biosciences plan to submit a BLA supplement for 1L ESCC in 2022 – SHANGHAI, China, and REDWOOD CITY, Calif., Sept. 16, 2021 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) today announced positive interim results from the pivotal study “JUPITER-06” (NCT03829969), a randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating toripalimab in combination with chemotherapy as a first-line therapy for patients with advanced or metastatic esophageal squamous cell carcinoma...